Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 2
1980 5
1981 8
1982 16
1983 32
1984 51
1985 65
1986 94
1987 85
1988 90
1989 91
1990 111
1991 112
1992 89
1993 107
1994 94
1995 84
1996 72
1997 81
1998 74
1999 62
2000 51
2001 53
2002 67
2003 51
2004 48
2005 64
2006 72
2007 76
2008 58
2009 59
2010 69
2011 79
2012 83
2013 81
2014 80
2015 75
2016 75
2017 72
2018 67
2019 86
2020 93
2021 90
2022 87
2023 100
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

2,987 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Alprazolam Use, Misuse, and Withdrawal.
Ait-Daoud N, Hamby AS, Sharma S, Blevins D. Ait-Daoud N, et al. J Addict Med. 2018 Jan/Feb;12(1):4-10. doi: 10.1097/ADM.0000000000000350. J Addict Med. 2018. PMID: 28777203 Free PMC article. Review.
: Alprazolam is one of the most widely prescribed benzodiazepines for the treatment of generalized anxiety disorder and panic disorder. ...We have replaced it in our manuscript with "misuse liability" as it reflects a more updated terminology consistent with the Diagnostic …
: Alprazolam is one of the most widely prescribed benzodiazepines for the treatment of generalized anxiety disorder and panic disorde …
Alprazolam for depression.
van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II. van Marwijk H, et al. Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007139. doi: 10.1002/14651858.CD007139.pub2. Cochrane Database Syst Rev. 2012. PMID: 22786504 Free PMC article. Review.
We considered six studies to have a high risk of bias.When alprazolam was compared with placebo for reduction in symptoms all estimates indicated a positive effect for alprazolam. ...The RD of all-cause withdrawals was -0.04 (95% CI -0.07 to 0.00; I(2) = 35%), in fa …
We considered six studies to have a high risk of bias.When alprazolam was compared with placebo for reduction in symptoms all estimat …
Alprazolam for tinnitus.
Huynh L, Fields S. Huynh L, et al. Ann Pharmacother. 1995 Mar;29(3):311-2. doi: 10.1177/106002809502900313. Ann Pharmacother. 1995. PMID: 7606078 Review.
There is insufficient evidence to support the use of alprazolam in the treatment of tinnitus. The Johnson trial is the only study to date assessing the role of alprazolam, and at best it is an open-label trial demonstrating activity. ...Furthermore, once efficacy is …
There is insufficient evidence to support the use of alprazolam in the treatment of tinnitus. The Johnson trial is the only study to …
Alprazolam for essential tremor.
Bruno E, Nicoletti A, Quattrocchi G, Filippini G, Zappia M, Colosimo C. Bruno E, et al. Cochrane Database Syst Rev. 2015 Dec 6;2015(12):CD009681. doi: 10.1002/14651858.CD009681.pub2. Cochrane Database Syst Rev. 2015. PMID: 26638213 Free PMC article. Review.
OBJECTIVES: PrimaryTo assess the efficacy and safety of alprazolam in the treatment of individuals with ET. SecondaryTo examine effects of alprazolam treatment on the quality of life of people with ET. ...Nine alprazolam-treated participants (75%) developed A …
OBJECTIVES: PrimaryTo assess the efficacy and safety of alprazolam in the treatment of individuals with ET. SecondaryTo examine effec …
Alprazolam and diazepam: addiction potential.
Juergens S. Juergens S. J Subst Abuse Treat. 1991;8(1-2):43-51. doi: 10.1016/0740-5472(91)90026-7. J Subst Abuse Treat. 1991. PMID: 2051498 Review.
Alprazolam and diazepam, the two most prescribed benzodiazepine anxiolytics in the United States, have potential for addictive use. ...Both drugs are rapidly absorbed and enter the brain tissue rapidly, leading to reinforcement. Alprazolam has a shorter half-life, w
Alprazolam and diazepam, the two most prescribed benzodiazepine anxiolytics in the United States, have potential for addictive use. .
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
Greenblatt DJ, von Moltke LL, Harmatz JS, Ciraulo DA, Shader RI. Greenblatt DJ, et al. J Clin Psychiatry. 1993 Oct;54 Suppl:4-11; discussion 12-4. J Clin Psychiatry. 1993. PMID: 8262889 Review.
The triazolobenzodiazepine alprazolam is biotransformed by hepatic microsomal oxidation, yielding two hydroxylated metabolites (4-hydroxy- and a-hydroxy-alprazolam) as the principal metabolic products. Both metabolites have lower benzodiazepine receptor affinity tha …
The triazolobenzodiazepine alprazolam is biotransformed by hepatic microsomal oxidation, yielding two hydroxylated metabolites (4-hyd …
Alprazolam-induced hypomania.
Reddy J, Khanna S, Anand U, Banerjee A. Reddy J, et al. Aust N Z J Psychiatry. 1996 Aug;30(4):550-2. doi: 10.3109/00048679609065031. Aust N Z J Psychiatry. 1996. PMID: 8887708
OBJECTIVE: There are reports of alprazolam-induced hypomania/mania. Here is a case report of a patient who developed hypomania during treatment with alprazolam, but not with diazepam, another benzodiazepine derivative. ...Clinicians have to be alert to the possibili …
OBJECTIVE: There are reports of alprazolam-induced hypomania/mania. Here is a case report of a patient who developed hypomania during …
The pharmacology of alprazolam: a review.
Huybrechts I. Huybrechts I. Clin Ther. 1991 Jan-Feb;13(1):100-17. Clin Ther. 1991. PMID: 2029716 Review.
Factors such as liver and kidney disease, smoking, age, sex, and obesity have minimal effects on alprazolam pharmacokinetics. A review of alprazolam-drug interactions revealed few that were clinically significant, except that cimetidine and oral contraceptives reduc …
Factors such as liver and kidney disease, smoking, age, sex, and obesity have minimal effects on alprazolam pharmacokinetics. A revie …
Alprazolam and depression: a review of risks and benefits.
Kravitz HM, Fawcett J, Newman AJ. Kravitz HM, et al. J Clin Psychiatry. 1993 Oct;54 Suppl:78-84; discussion 85. J Clin Psychiatry. 1993. PMID: 8262892 Review.
Therapeutic efficacy for depression and panic disorder has been demonstrated with the triazolobenzodiazepine alprazolam. However, potentially serious adverse events, including depression and suicide attempts, have been reported in patients taking this medication. In this p …
Therapeutic efficacy for depression and panic disorder has been demonstrated with the triazolobenzodiazepine alprazolam. However, pot …
The role of alprazolam for the treatment of panic disorder in Australia.
Moylan S, Giorlando F, Nordfjærn T, Berk M. Moylan S, et al. Aust N Z J Psychiatry. 2012 Mar;46(3):212-24. doi: 10.1177/0004867411432074. Epub 2012 Jan 5. Aust N Z J Psychiatry. 2012. PMID: 22391278 Review.
OBJECTIVE: To investigate the potential impact of increasing prescription rates of alprazolam for the treatment of panic disorder (PD) in Australia through a review of efficacy, tolerability and adverse outcome literature. ...Almost no evidence is available comparing al
OBJECTIVE: To investigate the potential impact of increasing prescription rates of alprazolam for the treatment of panic disorder (PD …
2,987 results